Genscript Biotech Corp
F:G51
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genscript Biotech Corp
F:G51
|
CN |
|
G
|
Global Ship Lease Inc
SWB:37H
|
UK |
|
N
|
Nippon Steel Corp
XMUN:NPS
|
JP |
Wall St Price Targets
G51 Price Targets Summary
Genscript Biotech Corp
According to Wall Street analysts, the average 1-year price target for G51 is 2.81 EUR with a low forecast of 2.22 EUR and a high forecast of 4.27 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is G51's stock price target?
Price Target
2.81
EUR
According to Wall Street analysts, the average 1-year price target for G51 is 2.81 EUR with a low forecast of 2.22 EUR and a high forecast of 4.27 EUR.
What is the Revenue forecast for Genscript Biotech Corp?
Projected CAGR
7%
Over the last 12 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 7 years is 7%.
What is the Gross Profit forecast for Genscript Biotech Corp?
Projected CAGR
-2%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 25%. The projected CAGR for the next 3 years is -2%.
What is the Operating Income forecast for Genscript Biotech Corp?
Projected CAGR
-3%
Over the last 12 years, the compound annual growth rate for Operating Income has been 34%. The projected CAGR for the next 7 years is -3%.
